296043
Cross site evaluation of the Strategic Prevention Framework State Incentive Grants: Analysis of state-level intervening variables
METHODS: Most states examined behavioral outcomes such as alcohol consumption and measured intervening variables (IVs) such as attitudes and norms and perceived risk of harm. We compared pre- and post-intervention community averages on intervening variables and outcomes and computed change scores. We then used non-parametric tests to assess statistically significant changes and differences.
RESULTS: Our analyses revealed that communities with SPF SIG funding generally reported more positive changes in IVs than negative or no changes. Despite extensive heterogeneity in our sample data, 20.3% of tests of association between intervening variables and outcomes were statistically significant in a positive direction, whereas only 4.2% were negatively statistically significant, essentially a 5:1 ratio of positive to negative associations.
CONCLUSIONS: While challenging, communities that have created positive changes in intervening variables most often also saw positive changes in outcomes. We conclude that the use of logic models helped states align prevention interventions with corresponding measures of change leading to stronger evaluations of cause and effect.
Learning Areas:
Conduct evaluation related to programs, research, and other areas of practiceEpidemiology
Program planning
Social and behavioral sciences
Learning Objectives:
Describe the Strategic Prevention Framework and explain how it is used at state and community levels.
Discuss important parameters of cross site evaluation of substance abuse prevention programs.
Explain the importance of intervening variables in planning substance abuse prevention programs.
Keyword(s): Drug Abuse Prevention and Safety, Evaluation
Qualified on the content I am responsible for because: I have been the federal project officer overseeing the national cross site evaluation of the Strategic Prevention Framework State Incentive Grant program since its inception. I am an epidemiologist who have been evaluating several public health programs at local, state and federal government agencies. My current scientific interests span across substance abuse prevention and mental health promotion.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.